These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 32171757)
1. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. Šimková A; Bušek P; Šedo A; Konvalinka J Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140409. PubMed ID: 32171757 [TBL] [Abstract][Full Text] [Related]
2. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy. Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873 [TBL] [Abstract][Full Text] [Related]
3. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669 [TBL] [Abstract][Full Text] [Related]
4. Targeting fibroblast activation protein in cancer - Prospects and caveats. Busek P; Mateu R; Zubal M; Kotackova L; Sedo A Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase? Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast activation protein in remodeling tissues. Jacob M; Chang L; Puré E Curr Mol Med; 2012 Dec; 12(10):1220-43. PubMed ID: 22834826 [TBL] [Abstract][Full Text] [Related]
7. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments. Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181 [TBL] [Abstract][Full Text] [Related]
8. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.]. Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930 [TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α. Keane FM; Nadvi NA; Yao TW; Gorrell MD FEBS J; 2011 Apr; 278(8):1316-32. PubMed ID: 21314817 [TBL] [Abstract][Full Text] [Related]
10. From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment. Zhang Z; Tao J; Qiu J; Cao Z; Huang H; Xiao J; Zhang T Cell Oncol (Dordr); 2024 Apr; 47(2):361-381. PubMed ID: 37726505 [TBL] [Abstract][Full Text] [Related]
11. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Hamson EJ; Keane FM; Tholen S; Schilling O; Gorrell MD Proteomics Clin Appl; 2014 Jun; 8(5-6):454-63. PubMed ID: 24470260 [TBL] [Abstract][Full Text] [Related]
12. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Brennen WN; Isaacs JT; Denmeade SR Mol Cancer Ther; 2012 Feb; 11(2):257-66. PubMed ID: 22323494 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma. Wong PF; Gall MG; Bachovchin WW; McCaughan GW; Keane FM; Gorrell MD Peptides; 2016 Jan; 75():80-95. PubMed ID: 26621486 [TBL] [Abstract][Full Text] [Related]
14. The role of fibroblast activation protein in health and malignancy. Fitzgerald AA; Weiner LM Cancer Metastasis Rev; 2020 Sep; 39(3):783-803. PubMed ID: 32601975 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248 [TBL] [Abstract][Full Text] [Related]
16. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin. LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells. Lai D; Ma L; Wang F Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695 [TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. Kelly T; Huang Y; Simms AE; Mazur A Int Rev Cell Mol Biol; 2012; 297():83-116. PubMed ID: 22608558 [TBL] [Abstract][Full Text] [Related]